A2 Biotherapeutics is an early-stage biotechnology company located in Southern California that develops novel medicines for serious illnesses.  We utilize an advanced targeting technology platform to increase the effectiveness of the body’s natural immune defenses. The company is funded by a syndicate of experienced biotechnology investors.